Life Sciences

IBM To Buy Ann Arbor Truven Health Analytics For $2.6 Billion

ANN ARBOR - The Watson Health business unit of IBM announced this week plans to acquire Truven Health Analytics, a provider of healthcare data analysis. The purchase price would be $2.6 billion. There was no immediate word on the future of Truven’s Ann Arbor headquarters staff. Truven will bring more than 8,500 clients, including U.S.

By |2016-02-19T11:22:47-05:00February 19th, 2016|ESD, Life Sciences|

Asterand Bioscience Wins $6.5 Million Contract From National Institutes Of Health

DETROIT - Asterand Bioscience says it has been awarded a five-year, $6.5 million contract from the National Institutes of Health to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium. The CPTAC is a coordinated effort to accelerate the understanding of the molecular basis of cancer by systematically identifying proteins

By |2016-02-18T09:36:51-05:00February 18th, 2016|ESD, Life Sciences|

Rubicon Genomics Inks New Deal With Beckman Coulter Life Sciences

ANN ARBOR - Rubicon Genomics announced Monday a new agreement with Beckman Coulter Life Sciences for distribution of its ThruPLEX Plasma-seq kits for research applications. It follows an announcement last fall that the kit has been automated for use with Beckman Coulter’s Biomek FX Automated Workstation, an automated liquid handling solution for laboratories worldwide. Further

By |2016-02-08T20:14:21-05:00February 8th, 2016|Life Sciences|

Michigan Bio-Industry Growth Summit Feb. 3 In Lansing

LANSING - Join leaders from the bio-industry, academia and policy realms on Feb. 3 at the Radisson Hotel in Lansing to discuss how to best unleash Michigan’s biosciences research and development and manufacturing potential to stimulate economic growth. Online registration ends Feb. 2. We will discuss the details of a forward-looking strategy for building a

By |2016-01-29T11:56:48-05:00January 29th, 2016|Life Sciences|

Millendo Therapeutics Sets Bar High For Venture Capital, Life Sciences Investment In Michigan

ANN ARBOR - In what is said to be the largest venture capital round in Michigan history, Millendo Therapeutics, formerly known as Atterocor Inc., announced this week it raised $62 million that will be used, in part, to pay new partner AstraZeneca for the rights to market a new cancer-fighting drug. The pharmaceutical giant also

By |2016-01-08T15:43:35-05:00January 8th, 2016|Life Sciences|

MichBio BioConnections Hosts Investor Meet And Greet Jan. 28

PLYMOUTH - Partner with Bank of America Merrill Lynch on Jan. 28 and meet one-on-one with Michio’s BioConnections investment partners at the Michigan Life Sciences Innovation Center. But you need to submit your executive summary by Jan. 22 to participate.  Bank of America Merrill Lynch (BofAML) is one of the world's leading financial institutions, serving

By |2016-01-07T16:47:55-05:00January 7th, 2016|Life Sciences|

SBIR’s Unplugged Ohio Aerospace Institute Feb. 2

CLEVELAND - Hear from Industry leaders as they share their SBIR program experiences and best practices. Learn how they've successfully applied for SBIR contracts, get your questions answered, and network with other successful and aspiring companies. Participating companies include Apollo Medical Devices, iRxReminder, Thermalin Diabetes and SPR Therapeutics. BONUS: Attendees of this event will gain

By |2016-01-05T19:43:31-05:00January 5th, 2016|Life Sciences|

US Senate Suspends Medical Device Tax For 2 Years

WASHINGTON DC  - Last Friday, the Senate passed a combined omnibus appropriations and tax extenders package 65-33 (27 Rs and 38 Ds).  Prior to that, the omnibus passed the House 316-113 and the extenders package by 318-109.  The legislation now goes to President Obama to be signed into law. The legislation had several measures of

By |2015-12-21T11:26:55-05:00December 21st, 2015|Featured, Life Sciences, Politics|

Enzo Life Sciences Offers Melatonin ELISA Kit

ANN ARBOR - Enzo Life Sciences has developed the ELISA immunoassays kit that provides a simple and accurate measurement of melatonin. Melatonin (N-acetyl-5-methoxytryptamine) is produced in the pineal gland and is a major component of the regulation of the circadian rhythm. Melatonin and its metabolites have demonstrated antioxidant properties and have been implicated in some

By |2015-12-08T20:02:37-05:00December 8th, 2015|Life Sciences|

Canadian Pharma Company To Market Armune Prostate Cancer Test

KALAMAZOO - The Apifiny blood test for prostate cancer developed by Kalamazoo-based Armune BioScience Inc. will be promoted by Quebec City, Quebec-based Aeterna Zentaris Inc. under a co-marketing agreement announced Tuesday. Apifiny is the only cancer specific, non-PSA blood test for the detection of prostate cancer. Under the co-marketing agreement, Aeterna will promote the test

By |2015-12-04T13:28:31-05:00December 4th, 2015|ESD, Life Sciences|